← Open Payments lookup

ANTONIOS KATSIGIANNIS: Open Payments

NPI 1629157276 · STAMFORD, CT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$2,356 in 82 payments from 26 companies in 2025. Trend: 2023 $3,563 · 2024 $3,310 · 2025 $2,356

Food & beverage: $2,356
CompanyPaymentsAmount
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)5$236
AstraZeneca Pharmaceuticals LP6$233
Novo Nordisk Inc4$197
Boehringer Ingelheim Pharmaceuticals, Inc.4$189
Otsuka America Pharmaceutical, Inc.9$188
Bayer Healthcare Pharmaceuticals Inc.8$165
Lilly USA, LLC7$143
Axsome Therapeutics, Inc.2$141
Merck Sharp & Dohme LLC3$130
ABBVIE INC.4$87

Products named: JARDIANCE, CAPLYTA, REXULTI, Kerendia, BREZTRI, Auvelity, Wegovy, CAPVAXIVE.

Industry payments across CT — which companies pay providers there.